Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Current Leases (2018 - 2026)

Champions Oncology has reported Current Leases over the past 9 years, most recently at $1.5 million for Q1 2026.

  • Quarterly results put Current Leases at $1.5 million for Q1 2026, up 6.62% from a year ago — trailing twelve months through Jan 2026 was $1.5 million (up 6.62% YoY), and the annual figure for FY2025 was $1.5 million, up 10.02%.
  • Current Leases for Q1 2026 was $1.5 million at Champions Oncology, roughly flat from $1.5 million in the prior quarter.
  • Over the last five years, Current Leases for CSBR hit a ceiling of $1.5 million in Q1 2026 and a floor of $72000.0 in Q2 2022.
  • Median Current Leases over the past 5 years was $1.3 million (2024), compared with a mean of $1.2 million.
  • Biggest five-year swings in Current Leases: soared 1577.78% in 2023 and later rose 6.62% in 2026.
  • Champions Oncology's Current Leases stood at $1.1 million in 2022, then grew by 12.53% to $1.3 million in 2023, then rose by 9.88% to $1.4 million in 2024, then grew by 8.85% to $1.5 million in 2025, then rose by 0.26% to $1.5 million in 2026.
  • The last three reported values for Current Leases were $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025) per Business Quant data.